Streptomyces rochei 7434AN4, a producer of lankacidin and lankamycin contains three large linear plasmids, pSLA2-L(200kb), M (100kb), and S (17 kb). Studies on the mutants of 7434AN4 having a different plasmid profile showed a parallel relationship between the presence of pSLA2-L and the production of both lankacidin and lankamycin. WhenpSLA2-Lwas transferred by protoplast fusion to S. rochei 2-39, a non-antibiotic-producing mutant of7434AN4which contained no detectable plasmid, the fusants gained the capacity to produce both antibiotics. From the physical maps of pSLA2-L and pSLA2-Ll , a deletion plasmid (160 kb) of pSLA2-L, the latter plasmid was determined to contain a symmetrical linear repeat composedof the right 80-kb part of pSLA2-L.Four other lankacidin-producing Streptomyces strains were also found to have distinctive large linear plasmids which hybridized with the pSLA2-L probe. These results support the involvement of pSLA2-L in the production of lankacidin and lankamycin in S. rochei 7434AN4. The plasmid SCP1, which carries the methylenomycin biosynthetic gene cluster in Streptomyces coelicolor A3 (2), was shown to be a giant linear plasmid of 350 kb by pulsed field gel electrophoresis (PFGE)12). In an effort to investigate the involvement of linear plasmids in antibiotic biosynthesis following SCP1, large linear plasmids were detected in five Streptomyces strains3). Amongthem, Streptomyces rochei 7434AN4had three linear plasmids of 200, 100 and 17 kb. This strain produces two structurally unrelated antibiotics, Iankacidin4'5), a 1 7-membered macrolide antibiotic and lankamycin6), a 1 6-membered macrolide antibiotic. The same strain was reported to possess plasmid pSLA2, which was the first linear plasmid isolated from bacteria7~9). The smallest of the threes plasmids was found to be identical to pSLA2. We named the three linear plasmids pSLA2-S, M, and L, respectively. Curing experiments of pSLA2-S by Hayakawa et al.7) suggested that pSLA2-S was involved in the lankacidin production.
The plasmid SCP1, which carries the methylenomycin biosynthetic gene cluster in Streptomyces coelicolor A3 (2) , was shown to be a giant linear plasmid of 350 kb by pulsed field gel electrophoresis (PFGE)12). In an effort to investigate the involvement of linear plasmids in antibiotic biosynthesis following SCP1, large linear plasmids were detected in five Streptomyces strains3). Amongthem, Streptomyces rochei 7434AN4had three linear plasmids of 200, 100 and 17 kb. This strain produces two structurally unrelated antibiotics, Iankacidin4'5), a 1 7-membered macrolide antibiotic and lankamycin6), a 1 6-membered macrolide antibiotic. The same strain was reported to possess plasmid pSLA2, which was the first linear plasmid isolated from bacteria7~9). The smallest of the threes plasmids was found to be identical to pSLA2. We named the three linear plasmids pSLA2-S, M, and L, respectively. Curing experiments of pSLA2-S by Hayakawa et al. 7) suggested that pSLA2-S was involved in the lankacidin production.
Based on these data, we selected S. rochei 7434AN4and other lankacidin-producing strains, to study the involvement of plasmid in antibiotic production. In this paper, we report the detection of large linear plasmids in all the lankacidin-producers tested and their homology by Southern hybridization. In particular, we describe the characterization of the three linear plasmids from S. rochei 7434AN4and the involvement of the largest plasmid, pSLA2-L, in the production of lankacidin and lankamycin.
Materials and Methods

Bacterial Strains and Media
Lankacidin-producers and nonproducing mutants used in this study are listed in Table 1 . S. rochei 7434AN4, 491 , and 6642GC1 were described previously by Hayakawa et al.n\ Other lankacidin-producers were obtained from ATCC(American Type Culture Collections, Rockville, U.S.A), JCM(Japan Collection of Microorganisms, Wako, Saitama, Japan), and IFO (Institute for Fermentation, Osaka, Japan). Mutants UVirradiation, NTGtreatment, and protoplast regeneration of S. rochei 7434AN4were performed by the methodsof Kinashi et al.13) . High temperature mutants were obtained by spreading the spores of S. rochei 7434AN4on YMagar plates and incubated at 42°C. Colonies grown at this temperature were picked and analyzed further by PFGE and bioautography.
Protoplast Fusion
Protoplasts of the lankacidin producers, S. rochei 7434AN4Rand 51252, and the nonproducers, S. rochei 2-39 and S. Hvidans TK64 were made and fused as previously described13). Colonies grown on R2YE14)plates were transferred to YMmaster plates and their properties were further studied.
Bioassay of the Antibiotic Activity and the Lankacidin Resistance Colonies to be tested were inoculated onto agar plugs containing YMmedium and incubated at 28°C for 5 days. The agar plugs were put on a bioassay plate and incubated at 37°C overnight. The bioassay plate was composed of two layers. The bottom layer contained TSBmedium-1 %agar, while the top layer contained TSB medium-0.7%agar supplemented with 2%of the overnight culture in TSBmediumof the indicator organism, M. luteus IAM386. Minimal inhibitory concentration of lankacidin against various mutants of S. rochei 7434AN4was determined by inoculating mycelial suspension of the mutants onto YMplates containing a series of concentrations oflankacidin C followed by incubating at 28°C for 3 days.
TLCBioautography
The lankacidin-producers and their mutants were reciprocally cultured in 100 ml of YMmediumin a 500ml Sakaguchi flask at 28°C for 3 days. The broth filtrates were extracted with an equal volume of ethyl acetate and concentrated in vacuo. The concentrates were applied to two silica gel TLCplates (Kieselgel 60 F254, Merck) and developed with a mixture of chloroform and methanol (10 : 1). Spots on the first TLCplate were detected under a UV light and then by spraying 10% sulfuric acid followed by heating. The second TLCplate was placed in contact with a bioautography plate for 20 minutes. After exposure to the TLC plate the bioautography plate was incubated at 37°C overnight. The inhibitory zones corresponding to lankacidin C and lankamycin appeared at Rf 0.50 and 0.70, respectively. A third inhibitory zone sometimes appeared at Rf 0.35. The UVspectrum of this substance (278 nm) suggested that it belongs the lankacidin group of antibiotics, but we did not characterize it further.
Pulsed Field Gel Electrophoresis
The DNAsamples of the lankacidin-producers for PFGEanalysis were prepared by the protoplast method as described previously (2) or by the mycelium method. 2 ml of mycelial suspension in TE25Suc15) and 2ml of molten 2.0% low-melting agarose in TE25Suc kept at 40°C were poured into a Falcon 3002 plate and mixed well. After solidifying the agarose at 4°C for 10 minutes, 4ml of lysozyme (2mg/ml) in TE25Sucwas added and incubated at 37°C for 1~4hours. The agarose gel was detached from the bottom of the plate and floated in the buffer during protoplasting. The lysozyme solution was replaced by 1ml of 0.5 m EDTA, 2ml ofpronase (5 mg/ml) in TE25Suc and lml of 10% SDS, and incubated at 50°C overnight. The buffer was replaced by 0.5 m EDTAand the plate could be stored at 4°C for several months. Weused contour-clamped homogeneous electric fields (CHEF)16) gel electrophoresis for PFGEanalysis. It was carried out at 15°C with a switching interval of 16 to 24 seconds at 170V in 0.5 x TBEusing 1.0% agarose gel. SDS-CHEFwas performed by adding 0.2 % sodium dodecyl sulfate (SDS) to the buffer and agarose gel. After PFGEthe gel was stained in an ethidium bromide solution (5 /ig/ml) for 30 minutes followed by washing in water for more than 1 hour.
EnzymeDigestion and Southern Hybridization Linear plasmids were separated by CHEFgel electrophoresis using low-melting agarose, excised out from the gel and digested with a restriction enzyme as described (2) . The digested fragments were separated again by the second CHEFand transferred to a nylon membranefilter for hybridization. To make probes, plasmids and DNAfragments were extracted from the gel by electrocution or by the glass powder method (Geneclean II, Bio101, Inc., La Jolla, CA) and labeled with digoxigenin-labeled dUTP (Beohringer, Mannheim,Germany). Hybridization and detection were carried out as recommendedby supplier's protocol (Beohringer).
Results
Various Mutants of S. rochei 7434AN4 with a Different Plasmid Profile Although Hayakawa et al.n) suggested the involvement of pSLA2-S in the lankacidin production in S. rochei 7434AN4 based on curing experiments, we detected two additional plasmids, pSLA2-L and M in the same strain. Wetested S. rochei 491, the cured strain of Hayakawaet al. used for their analysis, and found that this strain lost all three linear plasmids.
In order to know the relation between the presence of the pSLA2 plasmids and the production of and resistance to the two antibiotics, we first made mutants having a different plasmid profile. The 7434AN4 strain was subjected to UVirradiation, NTGtreatment, protoplast regeneration, and growing at a high temperature. Colonies with no or weak antibiotic activity were selected for further studies. Somemutants were further mutagenized by an additional treatment in order to obtain all possible different combination of the three plasmids except the one containing only pSLA2-S ( Fig. 1A and Table 2 ). S. rochei 51252, a mutant with only pSLA2-L obtained by UVirradiation of the 7434AN4 strain, was further subjected to protoplast regeneration to make plasmid-negative mutants, S. rochei 2-39 and 3-44. S. rochei 1-2, a UV-irradiated mutant with pSLA2-Mand S, was further incubated at a high temperature in order to obtain strain K3A-12 with only the pSLA2-Mplasmid. High temperature culture of the 51252 strain gave a mutant KE32 which contained a 160-kb linear plasmid named pSLA2-Ll. Protoplast fusion of S. rochei 7434AN4R,a spontaneous rifampicin-resistant mutant of 7434AN4, and 2-39 gave a fusant F-7 containing pSLA2-L and S. (A) CHEFelectrophoresis.
CHEFwas carried out at 15°C with a switching interval of 18 seconds at 130 V for 19 hours in 0.5 x TBE using 1.0% agarose gel. (B) and (C) Southern hybridization. Hybridization was carried out using digoxigenin-labeled pSLA2-L and lambda DNA(B), and digoxigenin-labeled pSLA2-S (C), respectively, as probes. Lanes: 1, 10, lambda DNAladder; 2, S. rochei 7434AN4; 3, 41227;
4, 51252; 5, 1-2; 6, F-7; 7, K3A-12; 8, 2-39; 9, KE32. temperature; PR, protoplast regeneration. MIC, minimal inhibitory concentration of lankacidin C (/xg/ml).
As summarized in Table 2 , all the mutants were analyzed by CHEFfor the presence of linear plasmids, by bioautography for the production of lankacidin and/or lankamycin, and by bioassay for the lankacidin resistance. The results clearly indicate a relationship between the presence of pSLA2-L and the production of the two antibiotics, lankacidin and lankamycin. All the non-producers were sensitive to lankacidin (the lankamycin sensitivity was not tested). S. rochei KE32containing pSLA2-Ll did not produce lankacidin nor lankamycin and was sensitive to lankacidin. In all the strains studied, production of the two antibiotics, lankacidin and lankamycin was always linked.
Physical Mapping of pSLA2-L and pSLA2-Ll Restriction endonucleases, Aflll, Asel, Spel, Sspl and Xbal did not cut pSLA2-L, while Dral, EcoRV, Hindlll and Hpal gave several fragments suitable for physical mapping. Numbers of the fragments with each restriction endonuclease and their sizes are summarizedin Table 3 .
As shown in Fig (Fig. 2, lane 4) . Double digestion with Dral and EcoRY afforded all the EcoRV fragments except EcoRY-B, determining the sequence EcoRY-A-B from the left end. The Hpal-A probe hybridized to the EcoRY-A and B fragments and one 19-kb fragment, while the Hpal-B probe hybridized to the EcoRY-E fragment and another 19-kb fragment. These results extended the sequence to EcoRY-A-B-C;one of the 19-kb fragments present here was named EcoRY-C. The order of the remained EcoRY-Dand E fragments was determined by hybridization of EcoRY-E to the inner Hindlll-B fragment to give the sequence EcoRY-A-B-C-E-D (Fig. 3) .
pSLA2-Ll is a 160-kb plasmid isolated from S. rochei KE32, a lankacidin-nonproducing and lankacidin-sensitive strain. Digestion of pSLA2-Ll with Hindlll gave the same fragments as those of pSLA2-L (J-faidlll-B, C, D and E) except Hindlll-A whose size changed to 75kb (A') ( Fig. 2A, lane 7) .
The total size (118kb) of these fragments was much smaller than the size of pSLA2-Ll itself. This discrepancy was solved by considering duplication of the B, C, D and E fragments. In accordance with The length of the fragments is given in Table 3 . SDS-CHEFand Southern blot analyses suggested that pSLA2-Lmight have a short TIR and a protein binding on both ends. pSLA2-Ll is a symmetrical linear plasmid containing the duplicated right 80-kb part of pSLA2-L in an inverted orientation. Ec, EcoRV; Dr, Dral; Hd, Hindlll; Hp, HpaL.
this interpretation, the intensity of the Hindlll-B fragment is stronger than that of the Hindlll-Af fragment instead of its small size. Therefore, pSLA2-Ll was deduced to be a symmetrical plasmid containing the duplicated right 80-kb part of pSLA2-L as shown in Fig. 3 .
Linear plasmids isolated from Streptomyces species had a terminal inverted repeat (TIR) on both ends9' 17~19>. In order to test the presence of TIR on pSLA2-L,a hybridization experiment was carried out. As shown in Fig. 2B , the i7/mIIII-D probe hybridized strongly to Hindlll-D itself and slightly to Hindlll-A, suggesting that a relatively short TIR is present on both ends. The Hindlll-D ofpSLA2-L hybridized to the corresponding band of pSLA2-Ll but not to the A' band. This result suggested the presence of TIR only on the Hindlll-D fragment, supporting the symmetrical structure ofpSLA2-L l. SDS-agarose Gel Electrophoresis The pSLA2-L plasmid was characterized by SDS-agarose gel electrophoresis. The gel samples of S. rochei 51252 were prepared with and without pronase treatment. The two samples were subjected to normal CHEFand SDS-CHEFto compare their 8 and 10) . These results suggest that a protein is bound to the termini of pSLA2-L as in the cases of other linear plasmids2'8'18). SDS-CHEFanalysis further indicated that a protein was bound to the Hindlll-D fragment of pSLA2-Ll but not to the Hindlll-A' fragment, supporting its symmetrical structure (data not shown).
Homology of the Linear Plasmids in S. rochei pSLA2-L, M, S, and LI from various S. rochei mutants were separated by CHEFgel electrophoresis and subjected to Southern hybridization. As shown in Fig. IB and 1C , the pSLA2-L probe hybridized to pSLA2-L itself and pSLA2-Ll strongly, and to pSLA2-Mweakly, but not to pSLA2-S. On the other hand, the pSLA2-S probe hybridized only to pSLA2-S itself. Therefore, pSLA2-L has strong homology to pSLA2-Ll, some homology to pSLA2-M, but no homology to pSLA2-S. These results together with the phenotypic correlation observed in the mutants suggest that pSLA2-Sis a different plasmid from pSLA2-L.
Transfer of pSLA2-L by Protoplast Fusion The pSLA2-Lplasmid was transferred by protoplast fusion from the rifampicin-resistant S. rochei 7434AN4Rto the rifampicin-sensitive S. rochei 2-39. Among150 colonies tested, 23 colonies were judged to originate from the 2-39 strain based on their rifampicin sensitivity.
The plasmid profiles and antibiotic-producing properties were also studied in these 23 strains. Seventeen (74%) of the colonies had plasmids. All the colonies except for the F-7 strain which contained pSLA2-L and S, had three plasmids. No rifampicin-sensitive revertant was detected from 48 1 regenerated colonies in a control experiment using only 7434AN4R.Bioautography was done for the 23 rifampicin-sensitive colonies and a complete correlation was seen again between the presence of pSLA2-Land antibiotic production. It should be stressed that the production ability of the two antibiotics was never separated in any fusant. Wealso tried to transfer pSLA2-L from 7434AN4R to S. lividans TK64 by protoplast fusion. S. lividans TK64 is a streptomycin-resistant and proline-requiring mutant of S. lividans 66, and does not produce lankacidin nor lankamycin. The fusants originated from the TK64strain were selected based on streptomycin resistance. All of the 221 streptomycin-resistant colonies were found to be proline-auxotrophs and did not have the antibiotic-producing ability. CHEF analysis showed that none of the pSLA2plasmids was transferred to 20 randomly selected colonies.
Large Linear Plasmids from Various
Lankacidin-pro ducers All the results described in the previous sections suggested that pSLA2-L rather than pSLA2-S is involved in the production of lankacidin and CHEFelectrophoresis was carried out at 170 V for 19 hours with 24-s pulse times. Digoxigenin-labeled pSLA2-L was used as a probe. Lanes; 1, lambda DNA DEC. 1994 lankamycin. If this is the case, we speculated that homologous linear plasmids would be present in the following lankacidin producing strains; S. griseofuscus JCM4276, S. violaceoniger IFO14166, S. rochei subsp. volubilis ATCC21250,S. rochei 6642GC1. All the strains were found to have large linear plasmids ( Fig. 5A and Table 1 ). S. rochei 6642GC1 has three plasmids of the same sizes with pSLA2-L, M, and S, respectively. Hirochika and Sakaguchi8) reported that this strain contained pSLAl, a linear plasmid almost identical to pSLA2-S except that its Smal-E fragment is 40 bp smaller than that of pSLA2-S. To study the homology of these plasmids to pSLA2-L, we did a hybridization experiment. As shown in Fig.  5B , the pSLA2-L probe hybridized to the linear plasmids from all four lankacidin-producers.
Discussion
Streptomyces rochei 7434AN4has three large linear plasmids, pSLA2-L, Mand S. Wemade various mutants from this strain and characterized their plasmid profile and antibiotic production capacity. The results indicated a parallel relationship between the presence of pSLA2-L and the production of both lankacidin and lankamycin. pSLA2-Lwas transferred by protoplast fusion from the rifampicin-resistant 7434AN4Rstrain to the rifampicin-sensitive nonproducer (2-39). Since protoplast fusion causes frequent recombinations between chromosomes, its analysis should be done carefully. But the 100 %correlation observed in the rifampicin-sensitive fusants suggest that pSLA2-Lis involved in antibiotic production.
The inability to isolate a mutant of S. rochei 7434AN4containing only pSLA2-S could have happened by chance or may suggest that the pSLA2-Lor Mplasmids are indispensable for the maintenance of pSLA2-S. In the yeast Kluyveromyces \actis, a linear plasmid pGKL2was reported to be necessary for the maintenance of another linear plasmid pGKLl20). Wesuccessfully transferred the pSLA2plasmids from S. rochei 7434AN4Rto 2-39 but not to S. lividans TK64. This result could also suggest that the S. rochei chromosomecontains a region necessary to maintain the pSLA2plasmids which is missing in the S. lividans chromosome.
From the physical map, pSLA2-Ll was deduced to be a symmetrical linear plasmid containing the right 80-kb part of pSLA2-L. Kikuchi et al.21 ) also reported the structure of a similar symmetrical linear plasmid, Fl formed during transformation of Saccharomyces cerevisiae by pGKLl. Comparison of the maps of pSLA2-L and pSLA2-Ll suggested that the antibiotic biosynthetic and resistant genes might be located on the deleted left part of pSLA2-L. The weak hybridization of the Hindlll-D fragment to the Hindlll-A fragment suggested the presence of a short TIR on the ends of pSLA2-L. Further, SDS-CHEF indicated that a protein is bound to the termini of pSLA2-L. Linear plasmids so far isolated from Streptomyces species have TIR on both ends and a terminal protein on the 5' ends. Therefore, these two properties seem to be commonin linear plasmids in Streptomyces species.
Westudied four other lankacidin-producers and found large linear plasmids in all the strains tested. The probe pSLA2-L hybridized to the plasmids from all the producers. Solenberg et al. 22 ) studied the transposition of Tn5096 in S. griseofuscus C581 which was derived from strain ATCC23916(JCM4276) used in this work. This transposon was randomly inserted into both the chromosomeand two linear plasmids of 200 and 65kb in this strain. In contrast we detected three plasmids in the JCM4276 strain. Insertion of Tn5096 into the larger plasmid eliminated the capacity of the strain to produce lankacidin, which supports the involvement of this plasmid in lankacidin production. Gravius et al. 23) reported that the otrB oxytracycline resistance gene was hybridized to a giant linear plasmid in Streptomyces rimosus. Therefore, large linear plasmids might be widely involved in antibiotic production in Streptomyces species in addition to the case of SCP1in methylenomycinproduction.
